Jakob Dupont

Dr. Jakob Dupont is an Independent Director at Pyxis Oncology, Inc., an Executive Partner at Sofinnova Investments, Inc., an Independent Non-Executive Director at Imugene Ltd. and an Advisor at Ambrx, Inc. He is on the Board of Directors at Bolt Biotherapeutics, Inc., Avenzo Therapeutics, Inc., Pyxis Oncology, Inc. and Imugene Ltd. Dr. Dupont was previously employed as an Independent Director by Apexigen, Inc., a Global Head-Research & Development by Atara Biotherapeutics, Inc., a Chief Medical Officer by Gossamer Bio, Inc., a VP & Global Head-Gynecologic Cancer Development by Genentech, Inc., a Chief Medical Officer & Senior Vice President by OncoMed Pharmaceuticals, Inc., a Global Director-Medical by Genentech, Inc., and a Faculty Member by Memorial Sloan Kettering Cancer Center.
He also served on the board at Apexigen America, Inc. He received his undergraduate degree from Vassar College, a graduate degree from New York University and a doctorate degree from Weill Cornell Medical College.